SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

11276	Companies
250579	Keywords
179215	Articles
136418	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 07/18/2025 at 07:00, 1 year 3 months ago

Communiqué de presse : Sanofi finalise l’acquisition de Blueprint Medicines
Sanofi finalise l’acquisition de Blueprint Medicines, ajoutant des médicaments sur le marché, un pipeline prometteur et l'expertise en mastocytose systémique. Acquisition bénéfique pour Sanofi, sans impact significatif sur les prévisions financières 2025

Acquisition Médicaments Sanofi Blueprint Medicines Mastocytose Systémique
BRIEF

published on 07/16/2025 at 07:05, 1 year 3 months ago

Sanofi : Désignation "fast track" pour le SAR446597 aux États-Unis

FDA Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track
BRIEF

published on 07/16/2025 at 07:05, 1 year 3 months ago

Sanofi: Fast track designation for SAR446597 in the United States

FDA Gene Therapy Sanofi Macular Degeneration Fast Track
PRESS RELEASE

published on 07/16/2025 at 07:00, 1 year 3 months ago

Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge
Sanofi obtient la désignation 'fast track' pour le traitement innovant de l'atrophie géographique liée à la dégénérescence maculaire. Le SAR446597 vise à inhiber des voies clés du complément pour une meilleure efficacité

Thérapie Génique Sanofi Dégénérescence Maculaire Fast Track Atrophie Géographique
PRESS RELEASE

published on 07/16/2025 at 07:00, 1 year 3 months ago

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
Sanofi's SAR446597 receives fast track designation in the US for geographic atrophy due to age-related macular degeneration, aiming to address unmet medical needs with innovative gene therapy

Gene Therapy Sanofi Fast Track Designation Geographic Atrophy SAR446597
PRESS RELEASE

published on 07/15/2025 at 18:30, 1 year 3 months ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 07/15/2025 at 18:30, 1 year 3 months ago

Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE

published on 06/30/2025 at 21:33, 1 year 4 months ago

Sanofi: Disclosure of trading in own shares
PRESS RELEASE

published on 06/30/2025 at 21:33, 1 year 4 months ago

Sanofi : Déclaration des transactions sur actions propres
BRIEF

published on 06/30/2025 at 07:35, 1 year 4 months ago

Sanofi Releases Q2 2025 Aide Mémoire

Forward-looking Statements Investor Information Financial Modeling Aide Mémoire Sanofi Q2 2025

Accesswire

Published on 11/04/2026 at 23:10, 2 hours 31 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 2 hours 41 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 2 hours 41 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 3 hours 26 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 3 hours 36 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 00:02, 1 hour 38 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 5 hours 59 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 6 hours 15 minutes ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 6 hours 57 minutes ago

EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 7 hours 35 minutes ago

Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production

Les Echos

Published on 11/04/2026 at 18:00, 7 hours 40 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 7 hours 40 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 7 hours 56 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 7 hours 56 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 7 hours 57 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE